Foundry Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$23.8M |
| 2 |
Nucor
NUE
|
+$10.9M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$10.6M |
| 4 |
Baker Hughes
BKR
|
+$7.49M |
| 5 |
VRNT
Verint Systems
VRNT
|
+$7.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$18.7M |
| 2 |
Universal Health Services
UHS
|
+$14.3M |
| 3 |
Citigroup
C
|
+$14.3M |
| 4 |
Packaging Corp of America
PKG
|
+$13.9M |
| 5 |
JPMorgan Chase
JPM
|
+$11.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.68% |
| 2 | Industrials | 14.52% |
| 3 | Healthcare | 11.3% |
| 4 | Technology | 9.77% |
| 5 | Energy | 7.08% |
No holdings matched the selected filter criteria.
Similar funds
Foundry Partners's Q1 2025 Portfolio in Review
As of Q1 2025, Foundry Partners held 286 positions worth $1.89B, down 5% from $1.99B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Foundry Partners withdrew a net $67M in Q1 2025, closing 27 positions and reducing 126 holdings. Its most notable exit was Walt Disney, an estimated $18.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Foundry Partners opened a new position in US Bancorp worth $21.7M.
- Foundry Partners's largest Q1 2025 buy was US Bancorp: 514,985 shares worth $21.7M.
- Foundry Partners added most to Jazz Pharmaceuticals in Q1 2025, an estimated $10.6M increase.
- Foundry Partners's biggest Q1 2025 reduction was Universal Health Services, cutting an estimated $14.3M.
- Foundry Partners fully exited Walt Disney in Q1 2025, selling an estimated $18.7M.
- Foundry Partners's ten largest holdings make up 18% of its $1.89B portfolio in Q1 2025.
- Foundry Partners opened 17 new positions and closed 27 in Q1 2025.
- Foundry Partners's portfolio value fell 5% quarter-over-quarter to $1.89B.
Based on Foundry Partners's 13F filing for Q1 2025, filed 5 May 2025.